Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12551896rdf:typepubmed:Citationlld:pubmed
pubmed-article:12551896lifeskim:mentionsumls-concept:C0376525lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C1366512lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C1334043lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:12551896lifeskim:mentionsumls-concept:C2697616lld:lifeskim
pubmed-article:12551896pubmed:issue15lld:pubmed
pubmed-article:12551896pubmed:dateCreated2003-4-7lld:pubmed
pubmed-article:12551896pubmed:abstractTextGrb7, Grb10, and Grb14 are members of a distinct family of adapter proteins that interact with various receptor tyrosine kinases upon receptor activation. Proteins in this family contain several modular signaling domains including a pleckstrin homology (PH) domain, a BPS (between PH and SH2) domain, and a C-terminal Src homology 2 (SH2) domain. Although SH2 domains are typically monomeric, we show that the Grb10 SH2 domain and also full-length Grb10 gamma are dimeric in solution under physiologic conditions. The crystal structure of the Grb10 SH2 domain at 1.65-A resolution reveals a non-covalent dimer whose interface comprises residues within and flanking the C-terminal alpha helix, which are conserved in the Grb7/Grb10/Grb14 family but not in other SH2 domains. Val-522 in the BG loop (BG3) and Asp-500 in the EF loop (EF1) are positioned to interfere with the binding of the P+3 residue of a phosphopeptide ligand. These structural features of the Grb10 SH2 domain will favor binding of dimeric, turn-containing phosphotyrosine sequences, such as the phosphorylated activation loops in the two beta subunits of the insulin and insulin-like growth factor-1 receptors. Moreover, the structure suggests the mechanism by which the Grb7 SH2 domain binds selectively to pTyr-1139 (pYVNQ) in Her2, which along with Grb7 is co-amplified in human breast cancers.lld:pubmed
pubmed-article:12551896pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:languageenglld:pubmed
pubmed-article:12551896pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:citationSubsetIMlld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12551896pubmed:statusMEDLINElld:pubmed
pubmed-article:12551896pubmed:monthAprlld:pubmed
pubmed-article:12551896pubmed:issn0021-9258lld:pubmed
pubmed-article:12551896pubmed:authorpubmed-author:HubbardStevan...lld:pubmed
pubmed-article:12551896pubmed:authorpubmed-author:GhirlandoRodo...lld:pubmed
pubmed-article:12551896pubmed:authorpubmed-author:SteinEvan GEGlld:pubmed
pubmed-article:12551896pubmed:issnTypePrintlld:pubmed
pubmed-article:12551896pubmed:day11lld:pubmed
pubmed-article:12551896pubmed:volume278lld:pubmed
pubmed-article:12551896pubmed:ownerNLMlld:pubmed
pubmed-article:12551896pubmed:authorsCompleteYlld:pubmed
pubmed-article:12551896pubmed:pagination13257-64lld:pubmed
pubmed-article:12551896pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:meshHeadingpubmed-meshheading:12551896...lld:pubmed
pubmed-article:12551896pubmed:year2003lld:pubmed
pubmed-article:12551896pubmed:articleTitleStructural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.lld:pubmed
pubmed-article:12551896pubmed:affiliationSkirball Institute of Biomolecular Medicine and Department of Pharmacology, New York University School of Medicine, New York, New York 10016, USA.lld:pubmed
pubmed-article:12551896pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12551896pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12551896pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12551896pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
entrez-gene:2887entrezgene:pubmedpubmed-article:12551896lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12551896lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12551896lld:pubmed